No Data
No Data
Kaposi Sarcoma Strategic Market Research Report 2024-2030, Competitor Profiles of 14 Players Including Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer - ResearchAndMarkets.com
Goldman Sachs Keeps Their Hold Rating on GlaxoSmithKline (GSK)
J.P. Morgan Remains a Sell on GlaxoSmithKline (GSK)
Muna Therapeutics Announces Strategic Alliance With GSK to Accelerate Development of Novel Treatments for Alzheimer's Disease
GSK to Amend, Extend Shingles Vaccine Partnership With Zhifei in China
GSK Partners With Rgenta Therapeutics to Develop Small Molecule Splice Modulators
No Data